CMPI stock forecast for 2023 – 2027

Are you interested in Checkmate Pharmaceuticals, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CMPI stock price in 2022-2027. Is CMPI a good long term stock? When should I take profit in Checkmate Pharmaceuticals stock? Buy or sell stock? Will CMPI stock price go up? What are analysts’ forecasts for CMPI stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. CMPI stock returns are also predicted based on historical data.

According to our research, CMPI stock is a bad long-term investment. CMPI share price has been in a bear cycle for the past year. Checkmate Pharmaceuticals, Inc. stock trend is negative.

Checkmate Pharmaceuticals company info

Industry Biotechnology
Address 245 Main Street, Cambridge, MA, 02142, United States
Website https://www.checkmatepharma.com

Forecasting

52 Week High: 2.05428 USD
52 Week Low: 0.000001 USD
1 Year Forecast: 0.00000099 USD
5 Year Forecast: 0 USD

Agilent Technologies info

Market Cap: 52.78M
52 Week Change: -13.0136%
52 Week High: 16.5 USD
52 Week Low: 2 USD
Beta: 0.893845
50 Day Moving Average: 2.69
90 Day Moving Average: 3.207
200 Day Moving Average: 4.1
Resistance Level: 2.4644
Pivot Point: 2.4644
Support Level: 2.3912
Enterprise Value: -23,306,200
Forward P/E: -0.78
Forward EPS: -2.79
Profit Margin: 0.00%
Shares Outstanding: 21,630,800
EBITDA: 0
Held Percent Institutions: 83.76%
PEG Ratio (5Y): -0.02
Trailing EPS: -2.728

Checkmate Pharmaceuticals stock forecasts for 2023-2027

DateOpen PriceClose PriceChange

Checkmate Pharmaceuticals Stock Forecast for 2023

January 2023 0 0 0%
February 2023 0 0 0%
March 2023 0 0 0%
April 2023 0 0 0%
May 2023 0 0 0%
June 2023 0 0 0%
July 2023 0 0 0%

Other companies stock forecasts